Modern consumers are health-minded and efficacy-driven. To meet their needs, CLR Berlin developed AnnonaSense CLR™, a highly effective and sustainable solution for increased skin health and well-being. It provides the skin with means to establish a sustainable homeostatic balance. The adaptogenic action of AnnonaSense CLR™ supports the endocannabinoid System (ECS) by activating the CB2 receptor. Inflammatory processes induced by the TRPV1 receptor, part of the skin’s endovanilloid system (EVS) are strongly ruled down and a stable balance between the ECS and EVS is established. AnnonaSense CLR™ makes the skin less sensitive and more balanced, even itch could perceivably be reduced. Skin appearance becomes clearly better and a consumer study showed that perception of well-being and quality of life were improved.
AnnonaSense CLR™ is obtained from Annona Cherimola, common name Cherimoya, an edible fruit originating from South America.